The US Food and Drug Administration has issued a warning letter to Cipla after receiving thousands of complaints of defective products in the last couple of years. In the warning letter issued on ...

Drugmaker Cipla continues to struggle with regulatory challenges which have caused delays in the launch of two key drugs--respiratory medication Advair and chemotherapy drug Abraxane- yet again.

Cipla has launched an innovative combination of 3 HIV/AIDS drugs, Viraday that needs to be taken just once a day for effective treatment. Cipla has launched an innovative combination of 3 HIV/AIDS ...

Cipla Q2 Results Live : Cipla declared their Q2 results on 29 Oct, 2024, showcasing a robust performance with a topline increase of 5.58% year-over-year. The profit surged by 15.18% compared to ...

Cipla share price fell the most in terms of percentage among all the 50 companies in the NSE Nifty today Cipla share price: Cipla Ltd shares fell the most in terms of percentage among all the 50 ...

This marks Cipla’s third investment in GoApptiv which will be made in a combination of equity shares and compulsorily convertible preference shares In June 2020, Cipla first acquired a 21.85% ...

Cipla Limited is an Indian multinational pharmaceutical company that is headquartered in Mumbai, Maharashtra. The company is primarily known for producing generic drugs for various therapeutic uses.

Cipla's consolidated revenue from operations stood at ₹7,051.02 crores during the quarter ended September from ₹6,678.15 crore in Q2FY24, a year-on-year jump of nearly 10.5%. The firm ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Cipla Ltd Q2 FY25 net profit jumped over 15 percent on-year to Rs 1,303 crore, beating Street expectations by a wide margin. A Moneycontrol poll of brokerages had pegged the drugmaker's second ...

On the contrary, HSBC has given a 'buy' recommendation on Cipla with the target slashed to Rs 1,755, implying substantial gains of as much as 19 per cent. Jefferies also has reiterated its hold call ...

New Delhi, Shares of Cipla on Tuesday jumped more than 7 per cent a day after the company reported a 32.25 per cent rise in its profit to Rs 1,068.41 crore in the third quarter. The company's ...